[1]
“A CRITICAL REVIEW ON GUILLAIN BARRE SYNDROME (ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY- AIDP) AND THEIR MANAGEMENT”, Int J Ayu Pharm Res, vol. 8, no. 11, pp. 64–68, Nov. 2020, doi: 10.47070/ijapr.v8i11.1684.